# SBRT-SG 05 (NCT02192788)

> Phase II Study of SBRT as Treatment for Oligometastases in Prostate Cancer

No report yet. It can be ordered.

- Drugs tested: none (the trial tests a strategy, not a drug)
- Indication: oligometastatic prostate cancer

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT02192788
- Phase: NA
- Status: COMPLETED
- Sponsor: Grupo de Investigación Clínica en Oncología Radioterapia
- Conditions: Oligometastatic Prostate Cancer
- Interventions: Stereotactic Body Radiation Therapy for Oligometastases
- Enrollment: 68
- Primary outcome: Number of patients without disease progression of prostate cancer treated by SBRT

## Indexed commentary on SBRT-SG 05 so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- 3 posts on X

## Order

Focused, $750 at most (a smaller delivered size costs its own price): https://www.erudio.com/contact?report=sbrt-sg-05-nct02192788